| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1930386 | Biochemical and Biophysical Research Communications | 2011 | 4 Pages |
Abstract
⺠The GSTP1 promoter is hypermethylated in over 90% of prostate cancer cases. ⺠The epigenetic effects of lycopene on prostate cancer have not been previously reported. ⺠Neither lycopene nor its putative metabolite, apo-10â²-lycopenal, altered DNA methylation of GSTP1 in LNCaP cells.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Ann G. Liu, John W. Jr.,